Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CDTX Cidara Therapeutics, Inc.

休市中 07-11 16:00:00 EDT

50.54

-0.34

-0.68%

盘后50.54

+0.000.00%

19:23 EDT

最高52.50	最低48.37	成交量49.70万
今开52.50	昨收50.88	日振幅8.13%
总市值10.57亿	流通市值8.67亿	总股本2,092万
成交额2,481万	换手率2.90%	流通股本1,716万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CDTX","market":"US","secType":"STK","nameCN":"Cidara Therapeutics, Inc.","latestPrice":50.535,"timestamp":1752264000000,"preClose":50.88,"halted":0,"volume":496998,"hourTrading":{"tag":"盘后","latestPrice":50.535,"preClose":50.535,"latestTime":"19:23 EDT","volume":32259,"amount":1630139.09,"timestamp":1752276213735},"delay":0,"floatShares":17159000,"shares":20924400,"eps":-26.745962,"marketStatus":"休市中","change":-0.345,"latestTime":"07-11 16:00:00 EDT","open":52.5,"high":52.5,"low":48.365,"amount":24810531.794424,"amplitude":0.08127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.745962,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1429070400000,"exchange":"NASDAQ","adjPreClose":50.88,"preHourTrading":{"tag":"盘前","latestPrice":52,"preClose":50.88,"latestTime":"09:28 EDT","volume":782,"amount":40764.90928,"timestamp":1752240480107},"postHourTrading":{"tag":"盘后","latestPrice":50.535,"preClose":50.535,"latestTime":"19:23 EDT","volume":32259,"amount":1630139.09,"timestamp":1752276213735},"volumeRatio":0.6112954358408467,"impliedVol":0.9617,"impliedVolPercentile":0.383},"requestUrl":"/m/hq/s/CDTX","defaultTab":"news","newsList":[{"id":"2545357932","title":"加拿大皇家银行：维持Cidara Therapeutics(CDTX.US)评级，由优于大市调整至优于大市评级, 目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2545357932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545357932?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:26","pubTimestamp":1750775160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","CDTX","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2545311445","title":"WBB Securities：重申Cidara Therapeutics(CDTX.US)评级，由强烈买入调整至强烈买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2545311445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545311445?lang=zh_cn&edition=full","pubTime":"2025-06-23 23:21","pubTimestamp":1750692088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","BK4539","CDTX","BK4007"],"gpt_icon":0},{"id":"2544726429","title":"HC Wainwright & Co.：假定Cidara Therapeutics(CDTX.US)买入评级, 目标价41.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544726429","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544726429?lang=zh_cn&edition=full","pubTime":"2025-06-18 20:03","pubTimestamp":1750248220,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：假定Cidara Therapeutics(CDTX.US)买入评级, 目标价41.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/18200351155012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CDTX"],"gpt_icon":0},{"id":"2544974715","title":"HC Wainwright & Co.：假定Cidara Therapeutics(CDTX.US)买入评级, 目标价4","url":"https://stock-news.laohu8.com/highlight/detail?id=2544974715","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544974715?lang=zh_cn&edition=full","pubTime":"2025-06-18 19:57","pubTimestamp":1750247875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CDTX","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2540068604","title":"Needham：维持Cidara Therapeutics评级，由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068604","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540068604?lang=zh_cn&edition=full","pubTime":"2025-06-04 19:02","pubTimestamp":1749034938,"startTime":"0","endTime":"0","summary":"Needham：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060419101197715f7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060419101197715f7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","LENZ"],"gpt_icon":0},{"id":"2537155049","title":"Cidara Therapeutics, Inc.盘中异动 急速下跌5.37%报24.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537155049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537155049?lang=zh_cn&edition=full","pubTime":"2025-05-24 01:00","pubTimestamp":1748019643,"startTime":"0","endTime":"0","summary":"北京时间2025年05月24日01时00分，Cidara Therapeutics, Inc.股票出现异动，股价急速下跌5.37%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为4125.16%、2235.85%、1062.17%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、170.40%、101.08%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052401004495009fe6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052401004495009fe6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","BK4539","CDTX"],"gpt_icon":0},{"id":"2535313951","title":"Cidara Therapeutics, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313951?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:42","pubTimestamp":1747402966,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时42分，Cidara Therapeutics, Inc.股票出现异动，股价快速拉升5.42%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1466.90%、1337.37%、742.09%，振幅较大的相关个股有Affimed N.V.、Pasithea Therapeutics Corp.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为345.83%、32.54%、22.50%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214246a480fa98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214246a480fa98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CDTX","LENZ","BK4539"],"gpt_icon":0},{"id":"2535878585","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨5.15%报20.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535878585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535878585?lang=zh_cn&edition=full","pubTime":"2025-05-15 23:38","pubTimestamp":1747323498,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日23时38分，Cidara Therapeutics, Inc.股票出现异动，股价快速上涨5.15%。截至发稿，该股报20.30美元/股，成交量15.8529万股，换手率1.22%，振幅5.75%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515233818a47fc3c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515233818a47fc3c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","BK4539","CDTX"],"gpt_icon":0},{"id":"2534274115","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534274115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534274115?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:55","pubTimestamp":1747058155,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时55分，Cidara Therapeutics, Inc.股票出现波动，股价大幅上涨5.58%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.83%。其相关个股中，Cytomx Therapeutics, Inc.、艾吉纳斯、内克塔治疗涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为420.38%、84.25%、61.10%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、艾吉纳斯，振幅分别为49.55%、35.18%、32.98%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221555594f48678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221555594f48678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","CDTX","LENZ"],"gpt_icon":0},{"id":"2534143005","title":"Guggenheim：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由33.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534143005","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534143005?lang=zh_cn&edition=full","pubTime":"2025-05-10 00:26","pubTimestamp":1746807978,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Cidara Therapeutics(CDTX.US)评级，由买入调整至买入评级, 目标价由33.00美元调整至35.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10002650280964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CDTX","LENZ"],"gpt_icon":0},{"id":"2534396044","title":"摩根大通证券公司：维持Cidara Therapeutics(CDTX.US)评级，由优于大市调整至优于大市评级, 目标价由46.00美元调整至47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534396044","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534396044?lang=zh_cn&edition=full","pubTime":"2025-05-09 22:56","pubTimestamp":1746802569,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Cidara Therapeutics(CDTX.US)评级，由优于大市调整至优于大市评级, 目标价由46.00美元调整至47.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09225650280382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","399975","CDTX","159848"],"gpt_icon":0},{"id":"2534480333","title":"Cidara Therapeutics, Inc.盘中异动 股价大涨5.04%报20.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480333?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:35","pubTimestamp":1746797715,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时35分，Cidara Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、艾切托涨幅较大，Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为483.39%、117.77%、11.54%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Protalix Biotherapeutics, Inc. 、Vor Biopharma Inc.，振幅分别为76.90%、15.22%、13.63%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213515a6d92d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213515a6d92d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","CDTX"],"gpt_icon":0},{"id":"2532065489","title":"Cidara Therapeutics, Inc.盘中异动 大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532065489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532065489?lang=zh_cn&edition=full","pubTime":"2025-05-01 00:36","pubTimestamp":1746031002,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日00时36分，Cidara Therapeutics, Inc.股票出现波动，股价快速下挫5.30%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Regulus Therapeutics Inc.、Abeona Therapeutics Inc.、Nutriband Inc.涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Onconetix, Inc.较为活跃，换手率分别为160.34%、33.64%、24.88%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Sol-Gel Technologies Ltd.，振幅分别为56.00%、37.52%、33.18%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501003642974bc5ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501003642974bc5ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CDTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2531804758","title":"Cidara Therapeutics, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531804758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531804758?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:30","pubTimestamp":1745933455,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时30分，Cidara Therapeutics, Inc.股票出现异动，股价快速跳水5.04%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Abeona Therapeutics Inc.较为活跃，换手率分别为128.55%、37.37%、10.80%，振幅较大的相关个股有Promis Neurosciences Inc.、Sutro Biopharma, Inc.、Genprex, Inc.，振幅分别为9.62%、5.19%、4.98%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213055a46c3ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213055a46c3ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CDTX","BK4007"],"gpt_icon":0},{"id":"2529921534","title":"Cidara Therapeutics, Inc.盘中异动 快速上涨5.49%报21.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529921534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529921534?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:30","pubTimestamp":1745339439,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时30分，Cidara Therapeutics, Inc.股票出现波动，股价大幅拉升5.49%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.01%。其相关个股中，Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Portage Biotech Inc.涨幅较大，Ocean Biomedical, Inc.、Portage Biotech Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为208.81%、145.65%、145.33%，振幅较大的相关个股有Scorpius Holdings, Inc.、Moolec Science Sa C/Wts 、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为102.79%、89.29%、75.29%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423003039aa2c76c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423003039aa2c76c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CDTX"],"gpt_icon":0},{"id":"2528227893","title":"Cidara Therapeutics, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528227893?lang=zh_cn&edition=full","pubTime":"2025-04-17 00:27","pubTimestamp":1744820820,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时27分，Cidara Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大，Briacell Therapeutics Corp.、Transcode Therapeutics, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为500.11%、246.29%、179.82%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为90.48%、49.00%、36.67%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417002700aa2c71cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417002700aa2c71cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CDTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2518221205","title":"Cidara Therapeutics, Inc.盘中异动 下午盘大幅跳水6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518221205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518221205?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:58","pubTimestamp":1741629503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时58分，Cidara Therapeutics, Inc.股票出现波动，股价急速下挫6.04%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5624.76%、3827.78%、992.55%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101582396406b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031101582396406b31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CDTX"],"gpt_icon":0},{"id":"2517583114","title":"Cidara Therapeutics(CDTX.US)：2024年Q4财报实现营收0美元，前值为1758.3万美元，预期值为30万美元；每股收益为-5.38美元，前值为-0.80美元，预期值为-4.10美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517583114","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517583114?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301845,"startTime":"0","endTime":"0","summary":"Cidara Therapeutics(CDTX.US)：2024年Q4财报实现营收0美元，前值为1758.3万美元，预期值为30万美元；每股收益为-5.38美元，前值为-0.80美元，预期值为-4.10美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CDTX"],"gpt_icon":0},{"id":"1150749820","title":"Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37)，低于预期$(3.62)","url":"https://stock-news.laohu8.com/highlight/detail?id=1150749820","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150749820?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:41","pubTimestamp":1741297272,"startTime":"0","endTime":"0","summary":"Cidara Therapeutics报告季度每股亏损$，低于分析师普遍预期的$，低48.34%。相比去年同期每股亏损$，下降了656.34%。以上内容来自Benzinga Earnings专栏，原文如下：Cidara $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 48.34 percent. This is a 656.34 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cidara Therapeutics 2024年第四季度GAAP每股收益$(5.37)，低于预期$(3.62)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTX"],"gpt_icon":0},{"id":"2516966374","title":"Cidara Therapeutics, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516966374?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:45","pubTimestamp":1740761152,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时45分，Cidara Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Cidara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2987.99%、493.03%、368.47%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为57.80%、48.19%、46.60%。Cidara Therapeutics, Inc.公司简介：Cidara Therapeutics Inc 正在开发免疫治疗，旨在帮助提高面临重病的患者的治疗标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010045529634388a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010045529634388a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CDTX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cidara.com","stockEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.9489},{"period":"3month","weight":1.7759},{"period":"6month","weight":1.1056},{"period":"1year","weight":3.488},{"period":"ytd","weight":0.88}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cidara Therapeutics, Inc.原本以K2 Therapeutics公司的名字于2012年12月在特拉华州注册成立，2014年7月更名为Cidara Therapeutics公司。公司是一家生物技术公司，专注于发现，开发和商业化新的抗感染剂用于治疗疾病是由护理疗法目前标准充分解决。 CD101是棘白菌素类，一类成熟的抗真菌剂。该公司最初的专有候选产品是其新化合物，CD101，对于严重的真菌感染的治疗配方。该公司的第一个产品是候补CD101静脉内，以前biafungin，一个潜在的每周一次静脉内，或IV，治疗被用于全身性真菌感染的治疗和预防的发展。该公司的第二个候选产品，CD101外用，原名topifungin，是一种外用制剂CD101用于治疗外阴阴道念珠菌病，或VVC，一个普遍的粘膜感染。 CD101局部是棘白菌素类抗真菌剂中的所述第一局部施用。此外，该公司已开发出专有的免疫治疗技术平台，CloudbreakTM，它用它来创建，旨在引导患者的免疫细胞来攻击和消灭病原体引起的感染性疾病的化合物。该公司正在开发其第一个断云开发的候选人，C001，用于治疗侵袭性曲霉病，引起真菌病原体，曲霉菌感染。公司正在评估更多的机会来扩大其断云免疫平台，传染病等领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.020189},{"month":2,"riseRate":0.3,"avgChangeRate":-0.018232},{"month":3,"riseRate":0.5,"avgChangeRate":0.008463},{"month":4,"riseRate":0.3,"avgChangeRate":-0.079235},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.000086},{"month":6,"riseRate":0.454545,"avgChangeRate":0.100606},{"month":7,"riseRate":0.363636,"avgChangeRate":0.009198},{"month":8,"riseRate":0.4,"avgChangeRate":0.011706},{"month":9,"riseRate":0.4,"avgChangeRate":0.017964},{"month":10,"riseRate":0.3,"avgChangeRate":-0.053421},{"month":11,"riseRate":0.6,"avgChangeRate":0.061206},{"month":12,"riseRate":0.5,"avgChangeRate":0.059112}],"exchange":"NASDAQ","name":"Cidara Therapeutics, Inc.","nameEN":"Cidara Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cidara Therapeutics, Inc.,CDTX,Cidara Therapeutics, Inc.股票,Cidara Therapeutics, Inc.股票老虎,Cidara Therapeutics, Inc.股票老虎国际,Cidara Therapeutics, Inc.行情,Cidara Therapeutics, Inc.股票行情,Cidara Therapeutics, Inc.股价,Cidara Therapeutics, Inc.股市,Cidara Therapeutics, Inc.股票价格,Cidara Therapeutics, Inc.股票交易,Cidara Therapeutics, Inc.股票购买,Cidara Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cidara Therapeutics, Inc.(CDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cidara Therapeutics, Inc.(CDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}